Category:Atypical antipsychotic: Difference between revisions
No edit summary |
|||
| Line 23: | Line 23: | ||
==Drug Trade Names of BrexpiprazoleBrexpiprazole Tablet== | ==Drug Trade Names of BrexpiprazoleBrexpiprazole Tablet== | ||
Rexulti is the trade name for Brexpiprazole: | Rexulti is the trade name for Brexpiprazole: | ||
==Drug Usage== | ==Drug Usage== | ||
| Line 109: | Line 108: | ||
==Pharmacokinetics== | ==Pharmacokinetics== | ||
*Absorption | *Absorption | ||
** | **Peak plasma concentration within 4 hours. | ||
*Metabolism | *Metabolism | ||
** | **Primarily metabolized by CYP3A4 and CYP2D6. | ||
*Excretion | *Excretion | ||
** | **25% in urine and 46% in feces. Terminal elimination half-life is approximately 91 hours. | ||
Initial effects: Some patients may begin to see improvements within 1 to 2 weeks of starting treatment. | |||
Full Therapeutic Effects: The best results are typically observed after 4 to 6 weeks for schizophrenia and major depressive disorder (MDD) For agitation associated with | |||
dementia due to Alzheimer's disease, significant results may be seen in about 12 weeks. | |||
==Drug Precautions== | ==Drug Precautions== | ||
Revision as of 03:49, 8 July 2024
Drug class: Atypical antipsychotic
Brexpiprazole (Rexulti)(中文:銳思定)
Common Strengths of Brexpiprazole Tablet
Brexpiprazole tablets are available in the following strengths:
- 0.25 mg
- 0.5 mg
- 1 mg
- 2 mg
- 3 mg
- 4 mg
Drug Trade Names of BrexpiprazoleBrexpiprazole Tablet
Rexulti is the trade name for Brexpiprazole:
Drug Usage
Brexpiprazole is used for:
- Treatment of schizophrenia
- Adjunctive treatment of major depressive disorder (MDD)
- Treatment of agitation associated with dementia due to Alzheimer's disease
Mechanism of Action
Brexpiprazole acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and as an antagonist at serotonin 5-HT2A receptors. It modulates dopaminergic and
serotonergic activity to improve symptoms of schizophrenia and depression
Route of Administration
Brexpiprazole is administered orally in the form of tablets or liquid solution.
Dosages
- Schizophrenia (Adults): Initial dose of 1 mg once daily, titrated to 2 mg on Day 5 to 7, and up to 4 mg by Day 8. Target dose: 2 to 4 mg daily. Maximum dose: 4 mg/day.
- Depression (Adults): Initial dose of 0.5 mg or 1 mg once daily, titrated to 2 mg daily. Maximum dose: 3 mg/day.
- Pediatric Schizophrenia (13-17 years): Initial dose of 0.5 mg once daily, titrated to 1 mg on Day 5 to 7, and up to 2 mg by Day 8. Maximum dose: 4 mg/day.
For patients with moderate to severe renal impairment, the dosage of brexpiprazole should be reduced to a maximum of 3 mg per day for schizophrenia and 2 mg per day for MDD.
No adjustment is needed for mild renal impairment.
Side Effects
| Frequency | Adverse reactions |
|---|---|
| Common | Weight gain |
| Akathisia (feeling of restlessness, constant urge to move) | |
| Headache | |
| Drowsiness/sleepiness | |
| Dizziness | |
| Nausea | |
| Constipation | |
| Indigestion/heartburn | |
| Increased appetite | |
| Fatigue/tiredness | |
| Tremor | |
| Stuffy or runny nose | |
| Uncommon | Neuroleptic malignant syndrome (high fever, muscle stiffness, confusion) |
| Tardive dyskinesia (uncontrolled muscle movements) | |
| High blood sugar/diabetes | |
| Orthostatic hypotension (dizziness when standing up) | |
| Seizures | |
| Low white blood cell count | |
| Difficulty swallowing | |
| Suicidal thoughts or behaviors (especially in young adults) | |
| Compulsive behaviors (gambling, sexual urges, binge eating) | |
| Cognitive impairment | |
| Impaired body temperature regulation | |
| Stroke in elderly patients with dementia-related psychosis | |
| Allergic reactions (rash, itching, difficulty breathing) |
Pharmacokinetics
- Absorption
- Peak plasma concentration within 4 hours.
- Metabolism
- Primarily metabolized by CYP3A4 and CYP2D6.
- Excretion
- 25% in urine and 46% in feces. Terminal elimination half-life is approximately 91 hours.
Initial effects: Some patients may begin to see improvements within 1 to 2 weeks of starting treatment.
Full Therapeutic Effects: The best results are typically observed after 4 to 6 weeks for schizophrenia and major depressive disorder (MDD) For agitation associated with
dementia due to Alzheimer's disease, significant results may be seen in about 12 weeks.
Drug Precautions
Pregnancy
Generally considered safe, but should be used under medical supervision.
Breastfeeding
Metformin is excreted in breast milk, but the risk to the infant is considered low.
Children and Elderly
- Not recommended for children under 10 years.
- Use with caution in the elderly due to the potential for decreased renal function.
Renal Impairment
- Contraindicated in patients with eGFR < 30 mL/min/1.73 m2.
- Dose adjustments required for eGFR 30-44 mL/min/1.73 m2.
Monitoring Requirements
- Regularly monitor renal function, blood glucose, and vitamin B12 levels.
- Monitor for signs of lactic acidosis, especially in patients with renal impairment.
The key symptoms of metformin-associated lactic acidosis (MALA) include:
| Gastrointestinal | Nausea and vomiting |
| Abdominal pain | |
| Diarrhoea | |
| Neurological | Confusion |
| Lethargy | |
| Resoiratory | Rapid breathing |
| Difficulty breathing | |
| Cardiovascular | Hypotension |
| Rapid heart rate | |
| General | Extreme tiredness |
| Feeling cold, especially in arms and legs | |
| Other | Dizziness |
| Lighteadedness |
It is important to note that these symptoms can be nonspecific and may overlap with other conditions. MALA is a medical emergency that requires immediate treatment.
Drug Interaction
- Cimetidine: This antacid can increase metformin levels in the blood by inhibiting its elimination.
- Diuretics, especially loop diuretics eg Frusemide: Can increase the risk of lactic acidosis
- Corticosteroids: May increase blood glucose levels, potentially reducing metformin's effectiveness
- NSAIDs: Long-term use may increase the risk of lactic acidosis, especially in those with reduced kidney function
FAQ
How Should I Take the Tablet?
- Take with meals to reduce gastrointestinal side effects.
- Swallow whole; do not crush or chew extended-release tablets.
What Should I Avoid While Taking?
- Avoid excessive alcohol consumption due to increased risk of lactic acidosis.
- Avoid skipping meals to prevent hypoglycemia.
What Happens if I Miss a Dose?
- Take the missed dose as soon as you remember unless it is almost time for the next dose.
- Do not double the dose to make up for the missed one.
Pages in category "Atypical antipsychotic"
The following 8 pages are in this category, out of 8 total.
